Sarepta Therapeutics Inc (SRPT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,972,057,000
EV to revenue ratio (TTM)
1.144
EV to ebitda
16.91
Financial Performance
Revenue (TTM)
1,974,344,000
Gross profit (TTM)
377,264,000
EBITDA
-17,533,000
Profitability
Operating margin (TTM)
13.00%
Profit margin
-6.93%
Return on assets (TTM)
-1.13%
Return on equity (TTM)
-9.48%
Per Share Metrics
Revenue per share (TTM)
19
EPS
-1.57
Diluted EPS (TTM)
-1.57
Book value
14.46
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
19.16
PEG ratio
159.25
Price to sales ratio (TTM)
0.999
Price to book ratio (TTM)
1.31
Growth
Quarterly earnings growth (YoY)
-34.30%
Quarterly revenue growth (YoY)
2,664.00%
Analyst Sentiment
Strong buy
0
Buy
8
Hold
11
Sell
3
Strong sell
2
Risk & Volatility
Beta
0.261